Getting latest data loading
Home / Morning Report / Morning Report

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 1 March 2022

Yesterday’s UK 100 Leaders Price (p) % Chg
BAE SYSTEMS PLC 719.6 10.2%
BUNZL PLC 2,969.0 7.6%
HIKMA PHARMACEUTICALS PLC 2,083.0 7.0%
BARRATT DEVELOPMENTS PLC 611.0 6.3%
ANTOFAGASTA PLC 1,521.0 5.1%
Yesterday’s UK 100 Laggards Price (p) % Chg
POLYMETAL INTERNATIONAL PLC 351.2 -56.0%
EVRAZ PLC 144.8 -29.3%
MONDI PLC 1571.5 -12.0%
COCA-COLA HBC AG-DI 1904.0 -10.9%
STANDARD CHARTERED PLC 532.8 -4.8%
Major World Indices Price % Chg 1 YEAR
UK 100 INDEX 7,458 -0.4% 13.2%
DOW JONES INDUS. AVG 33,893 -0.5% 9.6%
DAX INDEX 14,461 -0.7% 4.9%
NIKKEI 225 26,845 1.2% -9.5%
S&P/ASX 200 INDEX 7,097 0.7% 4.5%
Commodities Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 97.29 1.64%
Brent Crude (ICE) USD/bbl. 100.99 3.12%
Gold Spot USD/t oz. 1,908 -0.1%
Copper (Comex) USd/lb. 452 1.5%
The UK 100 is called to open -8 points today at 7450.

1 Day; 12 Months

Click graph to enlarge

Markets Overview:

 

The UK 100 is called to open -8 points today at 7450.  The UK 100 looks set for a steady start today in comparison to other recent sessions, this comes as markets globally picked up overnight despite the shock from the heavy sanctions imposed on Russia.  US markets closed higher and Asian markets also improved during the day.

 

 

Company News & Broker Comments:

 

Company News:

 
Abrdn reports a FY pretax profit of £1.12bn (2020: £838m) and an adjusted diluted EPS of 13.7p (2020: 8.8p).
 
AstraZeneca closes collaboration & license agreement with Neurimmune to develop N1006, paying $30m up front and up to $730m on milestones.
 
Croda International reports a 2021 pretax profit of £411.5m as underlying sales increased 26% YoY. They expect to grow in 2022 in line with medium-term expectations.
 
Flutter Entertainment reports a FY pretax loss of £288.4m, swinging from a £1.1m profit YoY. FY cost of sales increased to £2.31bn and they have decided to not reinstate their dividend amid deleveraging.
GlaxoSmithKline says the EMA accepts marketing authorisation application for daprodustat.
Hochschild Mining gets "significant" increase in mineral resource at Snip gold project in Canada.
Shell will exit all its Russian operations becoming the latest major Western energy company to quit since Russia's invasion of Ukraine.

Broker Comments

JP Morgan Upgrades ITM Power to Overweight from Neutral (10 buys / 6 Holds / 1 Sell)
JP Morgan Upgrades Mondi to Overweight from Neutral (5 Buys / 6 Holds / 0 Sells)
Morgan Stanley Upgrades Rightmove to Equal Weight from Underweight (5 Buys / 4 Holds / 6 Sells)

 

Reporting Today:

 

Croda International

 

Flutter Entertainment

 

Intertek Group

 

Man Group

 

Reach

 

Rotork

 

Travis Perkins

 

abrdn

 

 

 

Reporting Tomorrow:

Aviva

 

Persimmon

 

Polymetal International

 

Vistry

 

Vivo Energy

 

Weir Group

 

 

 

In Focus Today:

 

Chinese NBS Manufacturing PMI

 

Chinese Non-Manufacturing PMI

 

Chinese Caixin Manufacturing PMI

 

German Retail Sales

 

German Markit Manufacturing PMI

 

UK Markit Manufacturing PMI

 

German Harmonized Index of Consumer Prices

 

US Markit Manufacturing PMI

 

US ISM Manufacturing PMI

 

BoE's Saunders speech

 

 

 

This Week's Ex-Dividends:

 

FTSE 100:

Dechra Pharmaceuticals

 

Hargreaves Lansdown

 

Barclays

 

FTSE 250:

Diversified Energy Company

 

Safestore Holdings

 

Ashmore Group

 

Scottish American Investment Company

 

Personal Assets Trust

 

HICL Infrastructure

 

Hays

 

Genus

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.